Author
Listed:
- Victor Abiola Adepoju
(Department of HIV and Infectious Diseases, Jhpiego Nigeria, Affiliate of Johns Hopkins University, Abuja 900911, Nigeria)
- Donald C. Udah
(JSI Research & Training Institute Inc. (JSI), Abuja 900911, Nigeria)
- Chinonye Alioha Ezenwa
(Department of Strategic Information, Jhpiego Nigeria, Affiliate of Johns Hopkins University, Abuja 900911, Nigeria)
- Jamiu Ganiyu
(National AIDS/STI and Viral Hepatitis Control Program, Federal Ministry of Health, Abuja 900911, Nigeria)
- Sumaiya Muhammad Lawal
(General Hospital Akwanga, Akwanga 960101, Nasarawa State, Nigeria)
- James Ambo Haruna
(Our Ladies of Apostles Hospital, Akwanga 960101, Nasarawa State, Nigeria)
- Qorinah Estiningtyas Sakilah Adnani
(Department of Public Health, Faculty of Medicine, Universitas Padjadjaran, Bandung 40161, West Java, Indonesia)
- Adamu Alhassan Ibrahim
(Director of Public Health Services, Nasarawa State Ministry of Health, Lafia 950101, Nasarawa State, Nigeria)
Abstract
Background: Viral hepatitis B and C (HBV and HCV) pose significant public health concern in Nigeria, where access to healthcare and treatment affordability are limited. This study investigated sociodemographic and clinical predictors of health insurance coverage and access to care among patients with HBV and HCV in Nasarawa State, Nigeria. Methods: A cross-sectional facility-based study was conducted at two secondary hospitals in Nasarawa State, Nigeria. Participants included patients diagnosed with HBV, HCV, or both who were ≥18 years old. Data were collected using a structured questionnaire covering sociodemographic and clinical information, health insurance details, and economic impact. Binary logistic regression was used to analyze the relationship between sociodemographic/clinical factors and health insurance status. Results: Out of 303 participants, 68% had health insurance, which mostly covered hepatitis screening and vaccination. Significant predictors of health insurance coverage included being aged 36–40 years (adjusted odds ratio [aOR]: 11.01, 95% confidence interval [CI]: 2.38–50.89, p = 0.002), having post-secondary education (aOR: 25.2, 95% CI: 9.67–65.68, p < 0.001), being employed (aOR: 27.83, 95% CI: 8.85–87.58, p < 0.001), and being HIV-positive (aOR: 4.06, 95% CI: 1.55–10.61, p = 0.004). Nearly all those insured (99%) faced restrictions in insurance coverage for viral hepatitis services. Conclusions: This study reveals that while health insurance coverage is relatively high among viral hepatitis patients in Nasarawa State, significant restrictions hinder access to comprehensive services, especially for vulnerable groups like younger adults, the unemployed, and PLHIV. Key factors influencing coverage include age, education, employment, and HIV status. Expanding benefit packages to include viral hepatitis diagnosis and treatment, raising awareness about viral hepatitis as part of insurance strategy, improving access for underserved populations, and integrating hepatitis services into existing HIV programs with strong policy implementation monitoring frameworks are crucial to advancing universal health coverage and meeting the WHO’s 2030 elimination goals.
Suggested Citation
Victor Abiola Adepoju & Donald C. Udah & Chinonye Alioha Ezenwa & Jamiu Ganiyu & Sumaiya Muhammad Lawal & James Ambo Haruna & Qorinah Estiningtyas Sakilah Adnani & Adamu Alhassan Ibrahim, 2024.
"Toward Universal Health Coverage: What Socioeconomic and Clinical Factors Influence Health Insurance Coverage and Restrictions in Access to Viral Hepatitis Services in Nasarawa State, Nigeria?,"
IJERPH, MDPI, vol. 21(10), pages 1-13, October.
Handle:
RePEc:gam:jijerp:v:21:y:2024:i:10:p:1373-:d:1500860
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:21:y:2024:i:10:p:1373-:d:1500860. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.